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To evaluate if endogenous extracellular adenosine influences sodium channel activity in nerve
terminals, we investigated how manipulations of extracellular adenosine levels influence 22Na
uptake by rat brain synaptosomes stimulated with veratridine (VT). To decrease extracellular
adenosine levels, adenosine deaminase (ADA) that converts adenosine into an inactive metabolite
was used. To increase extracellular adenosine levels, we used the adenosine deaminase inhibitor
erythro-9(2-hydroxy-3-nonyl) adenine (EHNA), as well as the inhibitor of adenosine transport,
nitrobenzylthioinosine (NBTI). ADA (0.1–5 U/ml) caused an excitatory effect on 22Na uptake
stimulated by veratridine, which was abolished in the presence of the adenosine deaminase
inhibitor erythro-9(2-hydroxy-3-nonyl) adenine (EHNA, 25 M). Both the adenosine uptake
inhibitor nitrobenzylthioinosine (NBTI, 1–10 M) and the adenosine deaminase inhibitor EHNA
(10–25 M) inhibited 22Na uptake by rat brain synaptosomes. It is suggested that adenosine is
tonically inhibiting sodium uptake by rat brain synaptosomes.
KEY WORDS: Adenosine; 22Na uptake; synaptosomes; adenosine deaminase; adenosine uptake inhibition.
INTRODUCTION
In 1977 one of us (J. A. Ribeiro) discussed with
Arsélio the role of presynaptic calcium in adenosine
modulation of neurotransmitter release. Previous results
suggested that calcium might be involved in this effect
(1), but it was very difficult to distinguish in electro-
physiological studies whether those substances could
modify calcium entry into stimulated nerve endings.
Arsélio suggested using as a preparation rat brain synap-
tosomes stimulated by potassium and studying 45Ca2
uptake. This suggestion introduced our group routinely
to the synaptosomal preparation and since our first pub-
lication in Biochemical Pharmacology (2), our group
published 23 original papers using synaptosomes as a
way to answer questions on presynaptic mechanisms. In
1983 Ana Sebastião discussed with Arsélio, who intro-
duced her to the Neurochemistry courses at the
Gulbenkian Institute of Science in Oeiras, the possibil-
ity of exploring 22Na uptake by synaptosomes stimu-
lated by veratridine as a way to know how purines might
modulate nerve conduction (3–4).
The last original work performed by our group
using synaptosomes is now presented as a way to honor
and to express our admiration for Arsélio, a guide of
science for all of us, since his move from the United
States in early 1970s to develop his scientific career at
the University of Coimbra.
It has been described that some substances block
epileptiform activity by associating their capacity to
increase endogenous adenosine, probably by inhibition
of adenosine deaminase, with the ability to directly
inhibit voltage gated sodium channels (see e.g., [5]). It is
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known that adenosine analogues by activating a
xanthine-sensitive adenosine receptor (6), inhibit sodium
uptake by rat brain synaptosomes stimulated by veratri-
dine (VT), an effect mediated through tetrodotoxin
(TTX)-sensitive sodium channels (4,6). As previously
discussed, the action of adenosine might be related to
inhibition of the voltage-gating system of the sodium
channels (4) as a result of an enhancement of the
intrasynaptosomal cyclic AMP concentrations (6).
Under basal conditions, synaptosomes from the rat
brain can release adenosine as such or this nucleoside
can originate from the metabolism of released nu-
cleotides, probably ATP. Released ATP is metabolized
into adenosine by ecto-ATPases (7) that convert ATP
into ADP and ADP is metabolized to AMP by
ADPases. AMP is converted to adenosine by the
enzyme ecto-5-nucleotidase (8). Extracellular adeno-
sine accumulation may also be induced by depolariza-
tion of synaptosomes with high K or veratridine (9).
Extracellular adenosine levels are regulated by uptake
into cells and by metabolism via the actions of extra-
cellular adenosine deaminase or intracellular adenosine
kinase (10). It therefore appeared of interest to inves-
tigate whether endogenous adenosine modulates 22Na
uptake by rat brain synaptosomes. This was studied by
incubating synaptosomes with the enzyme that
hydrolyses adenosine into inactive metabolites, adeno-
sine deaminase (ADA), as well as with the adenosine
deaminase inhibitor erythro-9(2-hydroxy-3-nonyl)
adenine (EHNA). The action of the adenosine uptake
inhibitor nitrobenzylthioinosine (NBTI) was also
investigated.
EXPERIMENTAL PROCEDURE
Preparation of Synaptosomal Fraction. A synaptosomal
fraction from rat brains without the cerebella was prepared as pre-
viously described (6). Briefly, three to four Wistar rats per experiment
(about 40 days old) were decapitated and the brains rapidly removed
into ice-cold 0.32 M sucrose buffered with Tris 20 mM to pH 7.4,
homogenized in 9 volumes of 0.32 M sucrose and centrifuged (0–4°C)
at 1500 g for 10 min. The supernatant was kept and the sediment
resuspended and centrifuged at the same speed and time. The super-
natants obtained from both centrifugations were mixed and centrifuged
at 9000 g for 20 min. After washing, the pellet was dispersed in 10
ml of 0.32 M of sucrose buffered with Tris 20 mM. Five-milliliter
aliquots of the suspension were layered carefully on 20 ml of 0.8 M
sucrose buffered with Tris 20 mM (pH 7.4) and centrifuged at 9000
g for 30 min. After centrifugation, the fraction retained at the inter-
face of 0.8 M sucrose (synaptosomal fraction) was collected and its
concentration adjusted to 0.4 M of sucrose by dilution with Tris 20
mM (pH 7.4). After centrifugation at 20 000 g for 30 min, the pellet
was resuspended in a sodium-free solution containing 130 mM choline
chloride, 5.4 mM KCl, 0.8 mM MgSO4, 5.5 mM glucose, and 50 mM
HEPES-Tris 50 (pH 7.4) and 1 mg/ml of bovine serum albumine
(BSA). Protein concentration was determined (11), and its value was
7.49  0.72 mg/ml.
Determination of 22Na Uptake by Synaptosomes. Sodium uptake
through the sodium channels was measured (12) and modified
according to a previous report (4). Samples (45 l) of synaptosomal
suspension plus 5 l of the test drugs or resuspension medium were
preincubated at 36°C for 10 min and with VT (20 M) for 1 min
followed by incubation with the 22Na (1 Ci/ml) containing solutions
(150 l) for 5 s. The incubation solutions contained besides the desired
concentrations of VT and the test drugs. 127 mM choline chloride,
5.4 mM KCl, 0.8 mM MgSO4, 5.5 mM glucose, 50 mM HEPES Tris
50 (pH 7.4), 2.8 mM NaCl 1 mg/ml of bovine serum albumine,
1.4 Ci/ml carrier-free 22NaCl (specific activity in the working
solution ≈0.5 Ci/M), and 5 mM of ouabain. Incubation was
terminated by adding 3 ml of ice-cold wash solution (163 mM of
choline chloride, 0.8 mM MgSO4, 1.4 mM CaCl2, 5 mM HEPES-Tris
(pH 7.4) and 1 mg/ml BSA) followed by filtration under reduced pres-
sure through 0.45-m cellulose filters, and the 22Na trapped on the
filters was counted in a scintillation counter. Nonspecific 22Na uptake
was determined using tetrodotoxin (1 M) in the VT-containing
solutions, and the data are presented as correct specific 22Na uptake
after subtraction of nonspecific uptake from total VT-induced 22Na
uptake. The specific 22Na uptake was 2.89  0.65 nM/mg of protein
and significantly different (P  .05, n  56) from nonspecific 22Na
uptake, which was 0.46  0.09 nM/mg of protein. In each experiment,
22Na uptake determinations were performed in triplicate. In each
experiment the 22Na uptake was determined in the absence (control)
and in the presence of the test drugs. When testing the ability of
EHNA to modify actions of ADA, EHNA was present both in control
and in test tubes
Statistics. Data are expressed as mean  SEM. P values of .05
or less (Student’s t test) were considered to represent significant dif-
ferences.
Drugs. Drugs used were tetrodotoxin (TTX), ouabain, adeno-
sine deaminase (type VI, 1782.2 U/ml, EC 3.5.4.4), veratridine (VT),
S-(p-nitrobenzyl)-6-thioinosine (NBTI) (Sigma), and erythro-9(2-hy-
droxy-3-nonyl)adenine (EHNA) (Boehringer). Carrier-free 22NaCl
(specific activity of purchased stock solution, ≈11 mCi/mM) was from
Amersham. All other chemicals and solvents were obtained from
common commercial sources.
RESULTS
Tonic Adenosine Modulation of 22Na Uptake in Rat
Brain Synaptosomes
The action of exogenous adenosine deaminase
(ADA) on VT-stimulated 22Na uptake by synaptosomes
is shown in Fig. 1. As can be seen, the effect of ADA
on 22Na uptake was enhanced, as the amount of ADA
in preincubation medium was increased from 0.1 to 2.5
U/ml. The averaged increase in the sodium uptake
caused by ADA (2.5 U/ml). When ADA (2.5 U/ml) was
incubated with synaptosomes in the presence of the
adenosine deaminase inhibitor erythro-9(2-hydroxy-3-
nonyl)adenine (EHNA), the excitatory effect of ADA on
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22Na uptake was attenuated 85% by 10 M EHNA, and
25 M of EHNA even completely abolished the exci-
tatory effect of ADA (n  2).
Effects of Erythro-9(2-Hydroxy-3-Nonyl) Adenine
and S-(p-Nitrobenzyl)-6-Thioinosine on 22Na
Uptake by Synaptosomes.
Figure 2 illustrates the effect of the adenosine deam-
inase inhibitor EHNA (10 and 25 M) on VT-induced
22Na uptake by brain synaptosomes. EHNA decreased
22Na uptake; the inhibitory effect obtained with 25 M
Fig. 1. Effect of adenosine deaminase (ADA) on specific 22Na uptake
by rat brain synaptosomes stimulated by VT. Incubation of the synap-
tosomal fraction (containing 0.28–0.42 mg of protein) with 22Na was
performed for 5 s. The ordinate represents the percentage modifica-
tion on veratridine-induced specific 22Na uptake; 0% is the specific
22Na uptake in the same experiment but in the absence of ADA (2.27
 0.17 nM/mg of protein) and 100% represents a complete inhibition
of 22Na uptake. Averaged nonspecific 22Na uptake observed in the
presence of VT (20 M)  TTX (1 M) in the same experiments
was 0.45  0.08 nM/mg of protein. * P  .05 compared with con-
trol. Means  SEM from eight experiments; in each experiment the
assays were performed in triplicate.
Fig. 2. Influence of inhibition of extracellular adenosine inactivation by
erythro-9(2-hydroxy-3-nonyl)adenine (EHNA) (a) and S-(p-nitroben-
zyl)-6-thioinosine (NBTI) (b) on VT-induced specific 22Na uptake by
rat brain synaptosomes. Synaptosomal fractions contained between
0.30–0.44 mg of protein. Synaptosomes were preincubated with the test
drugs for 10 min and with VT (20 M) for 1 min before addition of
the 22Na-containing solutions. Incubation of the synaptosomal fraction
with 22Na (specific activity 0.5 Ci/M of Na) was performed for 5 s.
The ordinate represents the percentage inhibition of veratridine-induced
specific 22Na uptake. (a) 0% (control) was 3.35  0.30 nM/mg of pro-
tein and averaged nonspecific 22Na uptake in the same experiments was
0.70  0.11 nM/mg of protein. Means  SEM of eight experiments for
each bar. * P  .05 compared with control; (b) 0% was 3.58  0.27
and nonspecific 22Na uptake in the same experiments was 0.82  0.08
nM/mg of protein. Means  SEM of nine experiments, except in the
case of 10 M NBTI (n  2). * P  .05 compared with control. In
each experiment the assays were performed in triplicate.
due to an increase of extracellular adenosine with sub-
sequent inhibition of voltage-dependent sodium chan-
nels, but a result of inhibition of an NBTI-sensitive
sodium transport. This is probably not the case because
NBTI did not influence the sodium transport, which is
not mediated by voltage-dependent sodium channels,
that is, that occurred in the presence of a supramaximal
concentration of TTX. Furthermore, as occurred with
NBTI, the adenosine deaminase inhibitor EHNA also
inhibited 22Na uptake. Although adenosine deaminase
has been considered to be cytosolic (but see [10]), there
have been some reports of a membrane-associated
adenosine deaminase in rat brain subfractions (15) and
inhibition of adenosine deaminase enhances presynaptic
actions of adenosine in the rat phrenic nerve (16). How-
ever, EHNA can also be taken up by purine transporters
and inhibit intracellular adenosine deaminase, with sub-
sequent enhancement of adenosine release.
Some drugs used in the treatment of brain dys-
functions, such as benzodiazepines (17) and pheno-
thiazines (18), interfere with mechanisms of inactivation
of endogenous adenosine, increasing its extrasynaptoso-
mal levels. Endogenous adenosine plays an important
role in neuronal excitability, especially in the hip-
pocampus (e.g., [19]). Adenosine and some of its ana-
logues possess anticonvulsant actions (see e.g., [20]).
On the other hand, the antiepileptic agents diphenyl-
hydantoin and carbamazepine, at therapeutic concentra-
tions, bind to voltage-dependent sodium channels (21).
The existence of a tonic modulation by adenosine of
sodium uptake by rat brain synaptosomes, together with
the well-known presynaptic and postsynaptic modula-
tory effects of adenosine (see e.g., [22]), support the
idea of multiple mechanisms underlying the inhibitory
action of the nucleoside on neuronal excitability, rein-
forcing its role as an endogenous anticonvulsant (23).
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